Measure ID: MIPS 259|Vascular Surgery|2026 Performance Year

Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured

Percent of patients undergoing endovascular repair of small or moderate non-ruptured infrarenal abdominal aortic aneurysms (AAA) that do not experience a major complication (discharged to home no later than post-operative day #2).

Outcome – High PriorityVascular SurgeryPatient Safety

Last updated: January 15, 2026

⚙️

Measure Specification

Denominator (Eligible Population)

Patients aged ≥ 18 years on date of encounter
ANDDiagnosis for non-rupture, infrarenal abdominal aortic aneurysms on date of encounter
ANDPatient procedure during the performance period

Denominator Exclusions3

For women: Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted CT or minor diameter on axial formatted CT: 9003F
Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted CT or minor diameter on axial formatted CT: 9004F
For men: Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted CT or minor diameter on axial formatted CT: 9004F

Numerator

Patients discharged to home no later than post-operative day #2 following EVAR of AAA.

Submission Codes (QDCs)

✓ Performance Met
G8826Patient discharged to home no later than post-operative day #2 following EVAR
✗ Performance Not Met
G8833Patient not discharged to home by post-operative day #2 following EVAR

Denominator Exceptions

None — this measure has no denominator exceptions.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.
VBCA Insights

💡Why This Measure Matters

Endovascular AAA repair is less invasive than open surgery, but patients should still go home quickly without major complications. This outcome measure tracks the percentage of EVAR patients discharged to home by post-op day 2. Good performance reflects careful patient selection, smooth perioperative management, and rapid recovery. If your discharge rate lags, review patient factors (frailty, comorbidities) and perioperative protocols to identify improvement opportunities.

📖Clinical Rationale

Elective repair of a small or moderate sized AAA is a prophylactic procedure and the mortality/morbidity of the procedure must be contrasted with the risk of rupture over time. Surgeons should select patients for intervention who have a reasonable life expectancy and who do not have a high surgical risk. Discharge to home within two days of endovascular AAA repair is an indicator of patients who were not frail prior to the procedure and who did not experience a major complication.

The proposed measure will therefore serve as an indicator of both appropriateness and overall outcome.

📝Clinical Recommendations

Elective repair is recommended for patients that present with a fusiform AAA ≥ 5.5 cm in maximum diameter, in the absence of significant comorbidities. Level of recommendation: Strong Quality of evidence: High Surveillance is recommended for most patients with a fusiform AAA in the range of 4.0 cm to 5.4 cm in maximum diameter. Level of recommendation: Strong Quality of evidence: Moderate

📋Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this procedure measure is submitted each time a procedure is performed during the performance period. The most recent quality data code will be used if the measure is submitted more than once.

Measure Details

MIPS 259View CMS Spec ↗
Year2026
TypeOutcome
PriorityHigh Priority
InverseNo
Topped OutNo
7-Point CapNo
SubmissionMIPS CQM

Specialty Sets

CMS-designated specialty sets containing this measure:

Vascular Surgery (12)

Related Measures

Vascular SurgeryMIPS 344

Rate of Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) for

Patient SafetyMIPS 130

Documentation of Current Medications in the Medical Record

Patient SafetyMIPS 145

Radiology: Exposure Dose Indices Reported for Procedures Using Fluoroscopy

Patient SafetyMIPS 155

Falls: Plan of Care

Patient SafetyMIPS 164

Coronary Artery Bypass Graft (CABG): Prolonged Intubation

Patient SafetyMIPS 168

Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration

Patient SafetyMIPS 181

Elder Maltreatment Screen and Follow-Up Plan

Patient SafetyMIPS 275

Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before

Patient SafetyMIPS 286

Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia

Patient SafetyMIPS 351

Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk

Patient SafetyMIPS 354

Anastomotic Leak Intervention

Patient SafetyMIPS 355

Unplanned Reoperation within the 30-Day Postoperative Period

Patient SafetyMIPS 357

Surgical Site Infection (SSI)

Patient SafetyMIPS 374

Closing the Referral Loop: Receipt of Specialist Report

Patient SafetyMIPS 384

Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating

Patient SafetyMIPS 385

Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement

Patient SafetyMIPS 392

Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation

Patient SafetyMIPS 393

Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation,

Patient SafetyMIPS 413

Door to Puncture Time for Endovascular Stroke Treatment

Patient SafetyMIPS 422

Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse

Patient SafetyMIPS 432

Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any Pelvic

Patient SafetyMIPS 513

Patient Reported Falls and Plan of Care

Official Resources

📄 CMS Measure Specification (PDF)🔗 QPP Quality Payment Program

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →
©